Physician profile
James Heming
NPI 1992734586
$1,067.80
in general payments reported to CMS, 2019-2025
19 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $288 · 2021: $72.93 · 2022: $36.92 · 2023: $141 · 2024: $129 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $239.26 | 2019-2020 | |
| Pacira Therapeutics, INC. | $214.57 | 2019-2021 | |
| Stryker Corporation | $107.29 | 2023 | Stryker |
| Depuy Synthes Sales INC. | $75.01 | 2019-2025 | Rigidloop, Fms |
| Bioventus LLC | $63.58 | 2020-2022 | |
| Ethicon US, LLC | $55.56 | 2019 | |
| Vericel Corporation | $52.40 | 2024-2025 | Maci |
| Avanos Medical | $38.19 | 2024 | On-Q* Pump and Accessories |
| Smith+Nephew, INC. | $31.66 | 2019 | |
| Acumed LLC | $28.84 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.85 | 2025 | |
| Mimedx Group, INC. | $23.82 | 2024 | |
| Anika Therapeutics, INC. | $19.37 | 2023 | X-Twist |
| Embody, INC. | $19.34 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.69 | 2025 | Iovera, Zilretta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $14.49 | 2024 | Tapestry |
| Orthofix Medical, INC. | $14.28 | 2023 | Physio-Stim |
| Solventum Corporation | $14.00 | 2024 | Prevena, V.A.C. Veraflo |
| Linvatec Corporation | $13.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Heming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.